
mdCurrent Conference Report: 72nd annual scientific sessions of the American Diabetes Association Intensive therapy initiated in newly diagnosed patients with type 2 diabetes preserved beta-cell function over the course of a 3.5-year study. The study’s lead investigator, Ildiko Lingvay, MD, recommended that “we try to achieve glycemic normalization as quickly…
Read more »
Early intensive therapy in type 2 diabetes may preserve beta cell function
mdCurrent Conference Report: 72nd annual scientific sessions of the American Diabetes Association Intensive therapy initiated in newly diagnosed patients with type 2 diabetes preserved beta-cell function over the course of a 3.5-year study. The study’s lead investigator, Ildiko Lingvay, MD, recommended that “we try to achieve glycemic normalization as quickly…
Read more »